Journal of Commercial Biotechnology

I’ve recently joined the Journal of Commercial Biotechnology as managing editor. Drop me a line if you would like to make a submission.

The most recent issue, edited by Neil Henderson, has just been published:

Volume 13, Issue 3


When should you fire the founder?PDF
William Bains
Constructing a processual model of communication in new product development from a multiple case study of biotechnology SMEsPDF
Jennifer Frahm, David C Ireland, Damian Hine
A maturing industry: Strategic patenting trends, US and academic dominance, and the global biotechnology landscapePDF
Gareth Williams
Measuring performance of field-medical programmes: Medical science liaison metrics consensusPDF
Jane Chin
The commercialisation of bioinformatics and the threat of open-source softwarePDF
Joseph F Greco
Intellectual property issues in nanotechnologyPDF
Lars Genieser, Michael Gollin
Fostering the process of adoption of personalised medicine: A matter of communication or a matter of cost?PDF
Pedro Reinares Lara, Emma Gutierrez de Mesa
Changing hopes and concerns about gene therapy in JapanPDF
Darryl Macer, Yoshihiro Okada, Makoto Nakagawa, MaryAnn Chen Ng, Masakazu Inaba

Legal and Regulatory Updates

Legal and regulatory updatePDF
John Wilkinson

Scroll to Top